Myricoidoside A - Compound Card

Myricoidoside A

Select a section from the left sidebar

Myricoidoside A

Structure
Zoomed Structure
  • Family: Plantae - Lamiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Monoterpene
Canonical Smiles OCC1O[C@@H](O[C@@H]2OC=C([C@@]3([C@H]2C(=C)[C@H](C3)O)O)C=O)C([C@H]([C@@H]1O)O)O
InChI InChI=1S/C16H22O10/c1-6-8(19)2-16(23)7(3-17)5-24-14(10(6)16)26-15-13(22)12(21)11(20)9(4-18)25-15/h3,5,8-15,18-23H,1-2,4H2/t8-,9?,10-,11+,12-,13?,14-,15-,16-/m0/s1
InChIKey WRZXADHWXXJLHL-IDZQAPNYSA-N
Formula C16H22O10
HBA 10
HBD 6
MW 374.34
Rotatable Bonds 4
TPSA 166.14
LogP -3.09
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 26
Formal Charge 0
Fraction CSP3 0.69
Exact Mass 374.12
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Clerodendrum myricoides Lamiaceae Plantae 54240

Showing of synonyms

  • Umereweneza D, Molel J.T, et al. (2021). Antiviral iridoid glycosides from Clerodendrum myricoides.. Fitoterapia, 2021, 155, 105055. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C=C1CCC(C12)C=COC2OC3CCCCO3

Level: 1

Mol. Weight: 374.34 g/mol

Structure

SMILES: C=C1CCC(C12)C=COC2

Level: 0

Mol. Weight: 374.34 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 374.34 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.5
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
-5.25
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.1

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.48
Plasma Protein Binding
39.78
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
2.18
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-3.28
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.95
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.12
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-7.61
Rat (Acute)
3.29
Rat (Chronic Oral)
3.12
Fathead Minnow
3.37
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
467.45
Hydration Free Energy
-16.71
Log(D) at pH=7.4
-1.2
Log(P)
-2.41
Log S
-0.38
Log(Vapor Pressure)
-13.39
Melting Point
142.47
pKa Acid
4.46
pKa Basic
4.03
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Lysozyme C II P11941 LYSC2_ONCMY Oncorhynchus mykiss 3 0.7126

Download SDF